Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic Avian influenza viruses

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 8981-8997

  Muramoto, Yukiko ^a   Shoemaker, Jason E ^b   Le, Mai Quynh ^c   Itoh, Yasushi ^d   Tamura, Daisuke ^a   Sakai Tagawa, Yuko ^a   Imai, Hirotaka ^a   Uraki, Ryuta ^a   Takano, Ryo ^a   Kawakami, Eiryo ^b   Ito, Mutsumi ^a   Okamoto, Kiyoko ^d   Ishigaki, Hirohito ^d   Mimuro, Hitomi ^a   Sasakawa, Chihiro ^a,e,f   Matsuoka, Yukiko ^b   Noda, Takeshi ^a   Fukuyama, Satoshi ^b   Ogasawara, Kazumasa ^d   Kitano, Hiroaki ^b,g,h,i,j   Kawaoka, Yoshihiro ^a,b,k   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g Systems Biology Institute   (Japan)

^h CANCER INSTITUTE   (Japan)

ⁱ SONY COMPUTER SCIENCE LABORATORIES INC   (Japan)

^j OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

^k UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; ASYMPTOMATIC INFECTION; AVIAN INFLUENZA VIRUS; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC ASSOCIATION; HOMEOSTASIS; IMMUNOSTIMULATION; INFLAMMATION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; MACACA FASCICULARIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; CELLS, CULTURED; DOGS; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLUENZA A VIRUS, H5N1 SUBTYPE; MACACA; MACACA FASCICULARIS; MADIN DARBY CANINE KIDNEY CELLS; ORTHOMYXOVIRIDAE INFECTIONS; PRIMATES; RESPIRATORY SYSTEM; SEVERITY OF ILLNESS INDEX; VIRUS REPLICATION;

EID: 84904864060     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00907-14     Document Type: Article

References (100)

1. WHO. 2013. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. Accessed 17 December 2013. World Health Organization, Geneva, Switzerland. http://www.who.int/ influenza/human_animal_interface/EN_GIP_20131008Cumulative NumberH5N1cases.pdf.
2. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen v Pham VTS, Vo CD, Le TQ, Ngo TT, Dao BK, Le PP, Nguyen TT, Hoang TL, Cao VT, Le TG, Nguyen DT, Le HN, Nguyen KT, Le HS, Le VT, Christiane D, Tran TT, Menno de, Schultz JC, Cheng P, Lim W, Horby P, Farrar J; World Health Organization International Avian Influenza Investigative Team. 2004. Avian influenza A (H5N1) in 10 patients in Vietnam. N. Engl. J. Med. 350:1179-1188. http://dx.doi.org/10.1056/NEJMoa040419.
3. Grose C, Chokephaibulkit K. 2004. Avian influenza virus infection of children in Vietnam and Thailand. Pediatr. Infect. Dis. J. 23:793-794. http://dx.doi.org/10.1097/00006454-200408000-00024.
4. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, Lochindarat S, Srisan P, Suwan P, Osotthanakorn Y, Anantasetagoon T, Kanjanawasri S, Tanupattarachai S, Weerakul J, Chaiwirattana R, Maneerattanaporn M, Poolsavathitikool R, Chokephaibulkit K, Apisarnthanarak A, Dowell SF. 2005. Human disease from influenza A (H5N1), Thailand, 2004. Emerg. Infect. Dis. 11:201-209. http://dx.doi.org/10.3201/eid1102.041061.
5. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY, Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. 2005. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353:1374-1385. http://dx.doi.org/10.1056/NEJMra052211.
6. Ng WF, To KF, Lam WW, Ng TK, Lee KC. 2006. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1-a review. Hum. Pathol. 37:381-390. http://dx.doi.org/10.1016/j.humpath.2006.01.015.
7. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, Ungchusak K, Angkasekwinai S, Chokephaibulkit K, Srisook K, Vanprapar N, Auewarakul P. 2007. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg. Infect. Dis. 13:708-712. http://dx.doi.org/10.3201/eid1305.060572.
8. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, Lau LT, Lu J, Gao Z, Zhang B, McNutt MA, Lu M, Anderson VM, Gong E, Yu AC, Lipkin WI. 2007. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370:1137-1145. http://dx.doi.org/10.1016/S0140-6736(07)61515-3.
9. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y. 2004. Reemergence of fatal human influenza A subtype H5N1 disease. Lancet 363:617-619. http://dx.doi.org/10.1016/S0140-6736(04)15595-5.
10. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha DO, Guan QY, Peiris JS, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207. http://dx.doi.org/10.1038/nm1477.
11. Barnard DL. 2009. Animal models for the study of influenza pathogenesis and therapy. Antivir. Res. 82:A110-A122. http://dx.doi.org/10.1016/j.antiviral.2008.12.014.
12. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, García-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 106:3455-3460. http://dx.doi.org/10.1073/pnas.0813234106.
13. Cillóniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F, Strong JE, Feldmann H, Kawaoka Y, Katze MG. 2009. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 5:e1000604. http://dx.doi.org/10.1371/journal.ppat.1000604.
14. Shinya K, Gao Y, Cilloniz C, Suzuki Y, Fujie M, Deng G, Zhu Q, Fan S, Makino A, Muramoto Y, Fukuyama S, Tamura D, Noda T, Eisfeld AJ, Katze MG, Chen H, Kawaoka Y. 2012. Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virusinduced viral pneumonia in the rhesus macaque. J. Virol. 86:6055-6066. http://dx.doi.org/10.1128/JVI.00365-12.
15. Le QM, Ito M, Muramoto Y, Hoang PV, Vuong CD, Sakai-Tagawa Y, Kiso M, Ozawa M, Takano R, Kawaoka Y. 2010. Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. J. Gen. Virol. 91:2485-2490. http://dx.doi.org/10.1099/vir.0.021659-0.
16. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y. 2005. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437:1108. http://dx.doi.org/10.1038/4371108a.
17. Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H. 2008. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 26:562-572. http://dx.doi.org/10.1016/j.vaccine.2007.11.031.
18. Shoemaker JE, Fukuyama S, Eisfeld AJ, Muramoto Y, Watanabe S, Watanabe T, Matsuoka Y, Kitano H, Kawaoka Y. 2012. Integrated network analysis reveals a novel role for the cell cycle in 2009 pandemic influenza virus-induced inflammation in macaque lungs. BMC Syst. Biol. 6:117. http://dx.doi.org/10.1186/1752-0509-6-117.
19. Zhang B, Horvath S. 2005. A general framework for weighted gene coexpression network analysis. Stat. Appl. Genet. Mol. Biol. 4:Article17. http://dx.doi.org/10.2202/1544-6115.1128.
20. Kaimal V, Bardes EE, Tabar SC, Jegga AG, Aronow BJ. 2010. Topp-Cluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Nucleic Acids Res. 38:W96-W102. http://dx.doi.org/10.1093/nar/gkq418.
21. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y. 2006. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444:378-382. http://dx.doi.org/10.1038/nature05264.
22. Hatta M, Gao P, Halfmann P, Kawaoka Y. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842. http://dx.doi.org/10.1126/science.1062882.
23. Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, Finkelstein DB, Xu X, Wang J, Ma J, Fan Y, Rakestraw KM, Webster RG, Hoffmann E, Krauss S, Zheng J, Zhang Z, Naeve CW. 2006. Large-scale sequence analysis of avian influenza isolates. Science 311:1576-1580. http://dx.doi.org/10.1126/science.1121586.
24. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA. 2008. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. U. S. A. 105: 4381-4386. http://dx.doi.org/10.1073/pnas.0800482105.
25. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, Tran TH, Do QH, Farrar J. 2005. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 352:686-691. http://dx.doi.org/10.1056/NEJMoa044307.
26. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, Nicholls JM, Chokephaibulkit K, Vanprapar N, Auewarakul P. 2005. Influenza A H5N1 replication sites in humans. Emerg. Infect. Dis. 11:1036-1041. http://dx.doi.org/10.3201/eid1107.041313.
27. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD. 2001. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 75:6687-6691. http://dx.doi.org/10.1128/JVI.75.14.6687-6691.2001.
28. Kuiken T, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD. 2003. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet. Pathol. 40:304-310. http://dx.doi.org/10.1354/vp.40-3-304.
29. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW, Guan Y, Peiris JS. 2007. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 13:147-149. http://dx.doi.org/10.1038/nm1529.
30. Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, Chapman R, Hertzog PJ. 2013. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41:D1040-D1046. http://dx.doi.org/10.1093/nar/gks1215.
31. Pichlmair A, Lassnig C, Eberle CA, Górna MW, Baumann CL, Burkard TR, Bürckstümmer T, Stefanovic A, Krieger S, Bennett KL, Rülicke T, Weber F, Colinge J, Müller M, Superti-Furga G. 2011. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat. Immunol. 12:624-630. http://dx.doi.org/10.1038/ni.2048.
32. Haller O, Arnheiter H, Lindenmann J, Gresser I. 1980. Host gene influences sensitivity to interferon action selectively for influenza virus. Nature 283:660-662. http://dx.doi.org/10.1038/283660a0.
33. Turan K, Mibayashi M, Sugiyama K, Saito S, Numajiri A, Nagata K. 2004. Nuclear MxA proteins form a complex with influenza virusNPand inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res. 32:643-652. http://dx.doi.org/10.1093/nar/gkh192.
34. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, García-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HW 4th. 2007. IFNstimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. U. S. A. 104: 1371-1376. http://dx.doi.org/10.1073/pnas.0607038104.
35. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, García-Sastre A, Zhang DE, Lenschow DJ. 2009. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouseadapted and non-mouse-adapted influenza B virus infection. J. Virol. 83:1147-1151. http://dx.doi.org/10.1128/JVI.00105-08.
36. Min JY, Krug RM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2=-5= oligo( A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U. S. A. 103: 7100-7105. http://dx.doi.org/10.1073/pnas.0602184103.
37. Malathi K, Dong B, Gale M, Jr, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819. http://dx.doi.org/10.1038/nature06042.
38. Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR, Hartmann R. 2009. Differential regulation of the OASL and OAS1 genes in response to viral infections. J. Interferon Cytokine Res. 29:199-207. http://dx.doi.org/10.1089/jir.2008.0050.
39. Chakrabarti A, Jha BK, Silverman RH. 2011. New insights into the role of RNase L in innate immunity. J. Interferon Cytokine Res. 31:49-57. http://dx.doi.org/10.1089/jir.2010.0120.
40. Nordmann A, Wixler L, Boergeling Y, Wixler V, Ludwig S. 2012. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J. 26:1290-1300. http://dx.doi.org/10.1096/fj.11-189886.
41. Zhu Z, Shi Z, Yan W, Wei J, Shao D, Deng X, Wang S, Li B, Tong G, Ma Z. 2013. Nonstructural protein 1 of influenza A virus interacts with human guanylate-binding protein 1 to antagonize antiviral activity. PLoS One 8:e55920. http://dx.doi.org/10.1371/journal.pone.0055920.
42. Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, Katinger H, Egorov A. 2005. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1β and 18. J. Gen. Virol. 86:185-195. http://dx.doi.org/10.1099/vir.0.80422-0.
43. Wang X, Hinson ER, Cresswell P. 2007. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96-105. http://dx.doi.org/10.1016/j.chom.2007.06.009.
44. Watanabe R, Leser GP, Lamb RA. 2011. Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin. Virology 417:50-56. http://dx.doi.org/10.1016/j.virol.2011.05.006.
45. Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, Palese P. 2011. Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J. Virol. 85:2480-2491. http://dx.doi.org/10.1128/JVI.02188-10.
46. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
47. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M. 2011. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 7:e1001258. http://dx.doi.org/10.1371/journal.ppat.1001258.
48. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, GenISIS Investigators, Investigators MOSAIC, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P. 2012. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484:519-523. http://dx.doi.org/10.1038/nature10921.
49. García-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72:8550-8558.
50. Wolff T, Ludwig S. 2009. Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J. Interferon Cytokine Res. 29:549-557. http://dx.doi.org/10.1089/jir.2009.0066.
51. Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, Mechti N, Vicenzi E. 2013. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. J. Virol. 87:4523-4533. http://dx.doi.org/10.1128/JVI.02548-12.
52. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T. 2000. Influenza virus NS1 protein counteracts PKRmediated inhibition of replication. J. Virol. 74:6203-6206. http://dx.doi.org/10.1128/JVI.74.13.6203-6206.2000.
53. Espert L, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNAgenomic viruses. J. Biol. Chem. 278:16151-16158. http://dx.doi.org/10.1074/jbc.M209628200.
54. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, Kashigi F, Goto S, Kameoka S, Fujikura D, Yamada T, Mizutani T, Kazumata M, Sato M, Tanaka J, Asaka M, Ohba Y, Miyazaki T, Imamura M, Takaoka A. 2011. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat. Immunol. 12: 37-44. http://dx.doi.org/10.1038/ni.1963.
55. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380-384. http://dx.doi.org/10.1038/nature10110.
56. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles ofMDA5and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
57. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S. 2007. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 36:263-269. http://dx.doi.org/10.1165/rcmb.2006-0283RC.
58. Matikainen S, Sirén J, Tissari J, Veckman V, Pirhonen J, Severa M, Sun Q, Lin R, Meri S, Uzé G, Hiscott J, Julkunen I. 2006. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 80:3515-3522. http://dx.doi.org/10.1128/JVI.80.7.3515-3522.2006.
59. Sirén J, Imaizumi T, Sarkar D, Pietilä T, Noah DL, Lin R, Hiscott J, Krug RM, Fisher PB, Julkunen I, Matikainen S. 2006. Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect. 8:2013-2020. http://dx.doi.org/10.1016/j.micinf.2006.02.028.
60. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M. 2007. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178:3368-3372. http://dx.doi.org/10.4049/jimmunol.178.6.3368.
61. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4:e1000151. http://dx.doi.org/10.1371/journal.ppat.1000151.
62. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-λ1) in response to influenza A infection. J. Immunol. 182:1296-1304. http://dx.doi.org/10.4049/jimmunol.182.3.1296.
63. Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, Dos Santos CC, Kawaoka Y, Akira S, Luster AD, Lu B, Penninger JM, Uhlig S, Slutsky AS, Imai Y. 2013. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am. J. Respir. Crit. Care Med. 187:65-77. http://dx.doi.org/10.1164/rccm.201203-0508OC.
64. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765. http://dx.doi.org/10.1146/annurev.immunol.19.1.683.
65. Li M, Liu X, Zhou Y, Su SB. 2009. Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses. J. Leukoc. Biol. 86:23-32. http://dx.doi.org/10.1189/jlb.1208761.
66. Tough DF. 2012. Modulation of T-cell function by type I interferon. Immunol. Cell Biol. 90:492-497. http://dx.doi.org/10.1038/icb.2012.7.
67. Engelmann B, Massberg S. 2013. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13:34-45. http://dx.doi.org/10.1038/nri3345.
68. Esmon CT, Xu J, Lupu F. 2011. Innate immunity and coagulation. J. Thromb. Haemost. 9:182-188. http://dx.doi.org/10.1111/j.1538-7836.2011.04323.x.
69. Eisenhut M, Wallace H. 2011. Ion channels in inflammation. Pflugers Arch. 461:401-421. http://dx.doi.org/10.1007/s00424-010-0917-y.
70. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319-323. http://dx.doi.org/10.1038/nature05495.
71. Levy DE, Marié IJ, Durbin JE. 2011. Induction and function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1:476-486. http://dx.doi.org/10.1016/j.coviro.2011.11.001.
72. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69: 912-920.
73. Hale BG, Randall RE, Ortín J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:2359-2376. http://dx.doi.org/10.1099/vir.0.2008/004606-0.
74. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. 2006. Avian flu: influenza virus receptors in the human airway. Nature 440: 435-436. http://dx.doi.org/10.1038/440435a.
75. Watanabe T, Shinya K, Watanabe S, Imai M, Hatta M, Li C, Wolter BF, Neumann G, Hanson A, Ozawa M, Yamada S, Imai H, Sakabe S, Takano R, Iwatsuki-Horimoto K, Kiso M, Ito M, Fukuyama S, Kawakami E, Gorai T, Simmons HA, Schenkman D, Brunner K, Capuano SV, III, Weinfurter JT, Nishio W, Maniwa Y, Igarashi T, Makino A, Travanty EA, Wang J, Kilander A, Dudman SG, Suresh M, Mason RJ, Hungnes O, Friedrich TC, Kawaoka Y. 2011. Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J. Virol. 85:13195-13203. http://dx.doi.org/10.1128/JVI.00859-11.
76. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, García-Sastre A. 2002. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. U. S. A. 99:10736-10741. http://dx.doi.org/10.1073/pnas.112338099.
77. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, Bu Z, Chen H, Wang C. 2010. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 184:5777-5790. http://dx.doi.org/10.4049/jimmunol.0903588.
78. Xu K, Klenk C, Liu B, Keiner B, Cheng J, Zheng BJ, Li L, Han Q, Wang C, Li T, Chen Z, Shu Y, Liu J, Klenk HD, Sun B. 2011. Modification of nonstructural protein 1 of influenza A virus by SUMO1. J. Virol. 85: 1086-1098. http://dx.doi.org/10.1128/JVI.00877-10.
79. Soubies SM, Volmer C, Croville G, Loupias J, Peralta B, Costes P, Lacroux C, Guérin JL, Volmer R. 2010. Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence. J. Virol. 84:6733-6747. http://dx.doi.org/10.1128/JVI.02427-09.
80. Zhao C, Hsiang TY, Kuo RL, Krug RM. 2010. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl. Acad. Sci. U. S. A. 107:2253-2258. http://dx.doi.org/10.1073/pnas.0909144107.
81. Dundon WG, Capua I. 2009. A closer look at the NS1 of influenza virus. Viruses 1:1057-1072. http://dx.doi.org/10.3390/v1031057.
82. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021-1025. http://dx.doi.org/10.1038/nature08260.
83. Yamamoto K, Ferrari JD, Cao Y, Ramirez MI, Jones MR, Quinton LJ, Mizgerd JP. 2012. Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia. J. Immunol. 189:2450-2459. http://dx.doi.org/10.4049/jimmunol.1200634.
84. Wong MH, Johnson MD. 2013. Differential response of primary alveolar type I and type II cells to LPS stimulation. PLoS One 8:e55545. http://dx.doi.org/10.1371/journal.pone.0055545.
85. Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, Lu X, Abernathy RA, Clarke M, Conn L, Kwong H, Lee M, Au G, Ho YY, Mak KH, Cox NJ, Fukuda K. 1999. Antibody response in individuals infected with avian influenzaA(H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J. Infect. Dis. 180:1763-1770. http://dx.doi.org/10.1086/315137.
86. Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, Mak KH, Lim W, Tam JS, Clarke M, Williams SG, Mounts AW, Bresee JS, Conn LA, Rowe T, Hu-Primmer J, Abernathy RA, Lu X, Cox NJ, Fukuda K. 2000. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J. Infect. Dis. 181:344-348. http://dx.doi.org/10.1086/315213.
87. Bridges CB, Lim W, Hu-Primmer J, Sims L, Fukuda K, Mak KH, Rowe T, Thompson WW, Conn L, Lu X, Cox NJ, Katz JM. 2002. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J. Infect. Dis. 185:1005-1010. http://dx.doi.org/10.1086/340044.
88. Cavailler P1, Chu S, Ly S, Garcia JM, Ha do Q, Bergeri I, Som L, Ly S, Sok T, Vong S, Buchy P. 2010. Seroprevalence of anti-H5 antibody in rural Cambodia, 2007. J. Clin. Virol. 48:123-126. http://dx.doi.org/10.1016/j.jcv.2010.02.021.
89. Buchy P, Vong S, Chu S, Garcia JM, Hien TT, Hien VM, Channa M, Ha do, Chau QNV, Simmons C, Farrar JJ, Peiris M, de Jong MD. 2010. Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. PLoS One 5:e10864. http://dx.doi.org/10.1371/journal.pone.0010864.
90. World Health Organization. 2008. Human cases of avian influenza A (H5N1) in North-West Frontier Province, Pakistan, October-November 2007. Wkly. Epidemiol. Rec. 83:359-364.
91. Wang TT, Parides MK, Palese P. 2012. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 335:1463. http://dx.doi.org/10.1126/science.1218888.
92. Le MQ, Horby P, Fox A, Nguyen HT, Le Nguyen HK, Hoang PM, Nguyen KC, de Jong MD, Jeeninga RE, Rogier van Doorn H, Farrar J, Wertheim HF. 2013. Subclinical avian influenza A(H5N1) virus infection in human, Vietnam. Emerg. Infect. Dis. 19:1674-1677. http://dx.doi.org/10.3201/eid1910.130730.
93. Zhang Z1, Zhang J, Huang K, Li KS, Yuen KY, Guan Y, Chen H, Ng WF. 2009. Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum.Pathol. 40:735-739. http://dx.doi.org/10.1016/j.humpath.2008.08.015.
94. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD. 2003. A primate model to study the pathogenesis of influenza A (H5N1) virus infection. Avian Dis. 47:931-933. http://dx.doi.org/10.1637/0005-2086-47.s3.931.
95. Chen Y, Deng W, Jia C, Dai X, Zhu H, Kong Q, Huang L, Liu Y, Ma C, Li J, Xiao C, Liu Y, Wei Q, Qin C. 2009. Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission. Arch. Virol. 154:227-233. http://dx.doi.org/10.1007/s00705-008-0277-5.
96. Herfst S, van den Brand JM, Schrauwen EJ, de Wit E, Munster VJ, van Amerongen G, Linster M, Zaaraoui F, van Ijcken WF, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Andeweg AC, Kuiken T. 2010. Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques. Vet. Pathol. 47:1040-1047. http://dx.doi.org/10.1177/0300985810374836.
97. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, Rosenke R, Shupert WL, Aranda CA, Mattoon JS, Kobasa D, Kobinger G, Li Y, Taubenberger JK, Richt JA, Parnell M, Ebihara H, Kawaoka Y, Katze MG, Feldmann H. 2011. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J. Virol. 85:1214-1223. http://dx.doi.org/10.1128/JVI.01848-10.
98. Richt JA, Rockx B, Ma W, Feldmann F, Safronetz D, Marzi A, Kobasa D, Strong JE, Kercher L, Long D, Gardner D, Brining D, Feldmann H. 2012. Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in cynomolgus macaques. PLoS One 7:e39990. http://dx.doi.org/10.1371/journal.pone.0039990.
99. Watanabe T, Imai M, Watanabe S, Shinya K, Hatta M, Li C, Neumann G, Ozawa M, Hanson A, Zhong G, Fukuyama S, Kawakami E, Simmons HA, Schenkman D, Brunner K, Capuano SV, III, Weinfurter JT, Kilander A, Dudman SG, Suresh M, Hungnes O, Friedrich TC, Kawaoka Y. 2012. Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients. J. Virol. 86:9361-9368. http://dx.doi.org/10.1128/JVI.01214-12.
100. Zhang K1, Xu W, Zhang Z, Wang T, Sang X, Cheng K, Yu Z, Zheng X, Wang H, Zhao Y, Huang G, Yang S, Qin C, Gao Y, Xia X. 2013. Experimental infection of non-human primates with avian influenza virus (H9N2). Arch. Virol. 158:2127-2134. http://dx.doi.org/10.1007/s00705-013-1721-8